 
Nor-Econ
Health economics in the treatment of inflammatory arthritis diseases
Project Manager
Associate
ABOUT THE PROJECT
The REMEDY center will facilitate research that improves the treatment of patients with rheumatic and musculoskeletal disorders. To bridge the gap between clinical research and political decisions concerning the healthcare services, it is necessary to estimate the cost and effectiveness of treatments, and the burden of disease.
NOR-ECON is a cross-cutting project, anchored in work package 6, which aims to incorporate health economic aspects into current REMEDY projects. NOR-ECON includes health economic evaluations, carried out either as part of a randomized, controlled trial (1), or as decision analysis modeling (2), but also analyses of health-related quality of life and costs from prospective studies or linkage of national health registries. The projects included in NOR-ECON thus obtain data from other studies, such as NOR-DMARD. NOR-DMARD is linked to the Cause of Death Registry, the Cancer Registry, the Norwegian Patient Registry, the Joint Prosthesis Registry, the Vaccine Registry, the FD Trygd and the A-ordningen, and we thus obtain information on the use of health services and participation in the workforce.
Projects that we are working on:
1. We have performed health economic evaluations of NOR-DRUM and NOR-GOUT.
2. Several master students from the Department of Health Management and Health Economics (HELED) at the University of Oslo have written their thesis on health economic topics using data from NOR-ECON.
WHO CAN JOIN?
This is not a project that accepts application from patients.
WHAT DOES THE STUDY INVOLVE?
This is not a project that accepts application from patients.
